TANDY REAGAN: Open Payments
NPI 1629724380 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 36 payments from 12 companies in 2025. Trend: 2023 $16 · 2024 $650 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $456 |
| UCB, Inc. | 4 | $107 |
| ABBVIE INC. | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Janssen Biotech, Inc. | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 1 | $72 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| ANI Pharmaceuticals, Inc. | 1 | $32 |
Products named: TAVNEOS, Bimzelx, TREMFYA, SAPHNELO, RINVOQ, COSENTYX, KRYSTEXXA, EVENITY.
Industry payments across TX — which companies pay providers there.
